Phase4 Partners Ltd Insider Profile
4 Followers
Phase4 Partners Ltd, former Ten Percent Owner at Albireo Pharma, holds 1.07M shares in Albireo Pharma (Ticker: ALBO). Most recently, Phase4 Partners Ltd Sold 100,000 shares of Albireo Pharma on Feb 01, 2018 for an estimated value of $3.44M.
Phase4 Partners Ltd's Trading History
You May Also Like
Phase4 Partners Ltd insider profile FAQ
What is the percentage of profitable transactions made by Phase4 Partners Ltd?
The percentage of profitable transactions made by Phase4 Partners Ltd is 100%.
What is the average return per transaction made by Phase4 Partners Ltd?
The average return per transaction made by Phase4 Partners Ltd is 40.60%.
What stocks does Phase4 Partners Ltd hold?
Phase4 Partners Ltd holds: ALBO stocks.
What was Phase4 Partners Ltd’s latest transaction?
Phase4 Partners Ltd’s latest transaction was an Informative Sell of $3.44M.
What was Phase4 Partners Ltd's most profitable transaction?
Phase4 Partners Ltd’s most profitable transaction was an Informative Buy of ALBO stock on November 7, 2016. The return on the trade was 57.30%.
What is Phase4 Partners Ltd's role in Albireo Pharma?
Phase4 Partners Ltd's role in Albireo Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
